Product Images Ipratropium Bromide And Albuterol Sulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Ipratropium Bromide And Albuterol Sulfate NDC 0487-0201 by Nephron Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

b5387e98-figure-01 - b5387e98 figure 01

b5387e98-figure-01 - b5387e98 figure 01

b5387e98-figure-02 - b5387e98 figure 02

b5387e98-figure-02 - b5387e98 figure 02

b5387e98-figure-03 - b5387e98 figure 03

b5387e98-figure-03 - b5387e98 figure 03

The text appears to be a list of numbers, symbols, and a medication name "Albuterol + Ipratropium" with the corresponding medication type "mimutoral Sulfote Inhalation Solution". It is likely a prescription label or package insert.*

b5387e98-figure-04 - b5387e98 figure 04

b5387e98-figure-04 - b5387e98 figure 04

This is a report on adverse events occurring in patients taking different treatments for respiratory and urogenital issues. The report shows data for three groups of patients taking two different types of medications (Albuterol and Ipratropium) and a combination of the two. The table lists the percentage of patients experiencing adverse events such as pain, chest pain, diarrhea, dyspepsia, nausea, leg cramps, bronchitis, lung disease, pharyngitis, pneumonia, and urinary tract infection.*

b5387e98-figure-05 - b5387e98 figure 05

b5387e98-figure-05 - b5387e98 figure 05

b5387e98-figure-06 - b5387e98 figure 06

b5387e98-figure-06 - b5387e98 figure 06

b5387e98-figure-07 - b5387e98 figure 07

b5387e98-figure-07 - b5387e98 figure 07

b5387e98-figure-08 - b5387e98 figure 08

b5387e98-figure-08 - b5387e98 figure 08

b5387e98-figure-09 - b5387e98 figure 09

b5387e98-figure-09 - b5387e98 figure 09

Ipratropium Bromide and Albuterol Sulfate is a medication prescribed for oral inhalation only. Each vial contains 0.5 mg Ipratropium bromide and 3 mg Albuterol sulfate equivalent to 2.5 mg Albuterol base. It comes in a unit-dose vial and should be stored between 2 and 25°C. The solution should be colorless, otherwise, discard it. This medication should be used only under a physician's direction, and contact them if you have additional questions.*

b5387e98-figure-10 - b5387e98 figure 10

b5387e98-figure-10 - b5387e98 figure 10

This is a description of a medication with the NDC code 0467-0201-03. It contains Ipratropium Bromide 0.5'mg + and Albuterol Sulfate 3mg. It is for oral inhalation use only. The rest of the text is not legible.*

b5387e98 figure 11

b5387e98 figure 11

This appears to be a description of a medication meant for oral inhalation with the brand name "Bneohron". The medication contains Ipratropium Bromide and Albuterol Sulfate, and the dosage is 0.5mg and 3mg respectively. The NDC code for this product is 0487020150. The rest of the text appears to be gibberish or unclear due to errors.*

b5387e98 figure 12

b5387e98 figure 12

This text provides patient instructions for using a medication called Ipratropium Bromide and Albuterol Sulfate for oral inhalation. The instructions include steps to follow when taking the medication using a nebulizer, as well as information on storage conditions and dosage. Patients are advised to read the information carefully every time their prescription is filled as information may have changed. The text also includes the manufacturer's information and contact details for customer service.*

b5387e98 figure 13

b5387e98 figure 13

b5387e98 figure 14

b5387e98 figure 14

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.